Celecoxib Shows a Surprising Benefit in Breast Cancer

Exploring Celecoxib for the Treatment of Breast CancerПодробнее

Celecoxib with or without zoledronic acid for hormone-naïve prostate cancerПодробнее

Neoadjuvant Durvalumab Shows Benefit in Triple-Negative Breast CancerПодробнее

Inside the Fight of Breast Cancer: A Personal StoryПодробнее

REACT: effect of celecoxib vs placebo as adjuvant therapy on DFS among patients with breast cancerПодробнее

Celecoxib in combination with chemotherapy is safe and efficacious for gastric cancer managementПодробнее

The REACT trial: Celecoxib vs placebo for primary breast cancerПодробнее

Surprising Alternative to Tamoxifen: Red Clover Explained.Подробнее

Controversial Celebrex for skin cancerПодробнее

What to look forward to in breast cancer at ASCO 2023Подробнее

Boston Hospitals Will Study Effects Of Aspirin On Breast Cancer RecurrenceПодробнее

Complementary Therapies to Help Manage Side Effects of Breast Cancer TreatmentПодробнее

Not All Women Who Are Clinically High-Risk Benefit from Extended Endocrine TherapyПодробнее

Balancing benefits and risks of anthracycline therapy in breast cancerПодробнее

Evaluating anthracycline benefits in breast cancer through recurrence scoresПодробнее

Studies Show Statins May Help Women Fight Cancer; The Time Of Day You Exercise MattersПодробнее

Composite biomarkers predictive of palbociclib + endocrine treatment benefit in early breast cancerПодробнее

'It's an ADC World': New Breast Cancer Data From ASCO 2022Подробнее

New Breast Cancer Treatment Producing Amazing ResultsПодробнее